HOME › DRUGS › BARICITINIB
ACTIVE SUBSTANCE / INN

BARICITINIB

Brand name(s): BARICITINIB, OLUMIANT, Olumiant
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA217585
ANDA217542
ACTIVE SUBSTANCE
Baricitinib
REGULATORS
FDA · EMA
SPONSORS / MAH
Eli Lilly Nederland B.V., AUROBINDO PHARMA LTD, MSN
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OLUMIANTANDA217585MSNPrescription
BARICITINIBANDA217542AUROBINDO PHARMA LTDDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OlumiantEli Lilly Nederland B.V.Authorised13/02/2017Arthritis, Rheumatoid

FULL INTELLIGENCE ON BARICITINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →